FDA clears initiation of phase III trial of siltuximab for COVID-19-associated ARDS July 2, 2020 No Comments
FDA clears first clinical trial of M-5049 in patients with COVID-19 pneumonia June 26, 2020 No Comments
First patient dosed in phase II study of TD-0903 for the treatment of ALI caused by COVID-19 June 26, 2020 No Comments
Palatin to develop PL-8177 for the treatment of COVID-19 and associated lung complications June 25, 2020 No Comments
Enrollment of first patient in phase II study of pamrevlumab in acute COVID-19 June 25, 2020 No Comments
miRagen reports preclinical observations with next-generation miR-29 mimic MRG-229 for IPF June 23, 2020 No Comments
Phase II trial explores axatilimab in patients with respiratory involvement secondary to COVID-19 June 18, 2020 No Comments
Aevi begins phase II study of CERC-002 in patients with COVID-19 pneumonia and acute lung injury June 18, 2020 No Comments
RSS